AllianceRx Walgreens Prime Revenue and Competitors
Estimated Revenue & Valuation
- AllianceRx Walgreens Prime's estimated annual revenue is currently $391.3M per year.
- AllianceRx Walgreens Prime's estimated revenue per employee is $201,000
Employee Data
- AllianceRx Walgreens Prime has 1947 Employees.
- AllianceRx Walgreens Prime grew their employee count by -1% last year.
AllianceRx Walgreens Prime's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Strategy and Growth | Reveal Email/Phone |
2 | VP, Revenue Cycle Management | Reveal Email/Phone |
3 | VP Payer Services | Reveal Email/Phone |
4 | VP, IT (Engineering, Architecture & Delivery) | Reveal Email/Phone |
5 | SVP, Specialty360 Strategy & Execution | Reveal Email/Phone |
6 | VP, Pharma and Financial Services | Reveal Email/Phone |
7 | Vice president, Patient Support Center | Reveal Email/Phone |
8 | VP, Health Systems Solutions & Decision Science | Reveal Email/Phone |
9 | Sr. Director Clinical Services | Reveal Email/Phone |
10 | National Director Nursing | Reveal Email/Phone |
AllianceRx Walgreens Prime Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.5M | 132 | N/A | N/A | N/A |
#2 | $10.1M | 50 | 14% | N/A | N/A |
#3 | $282.6M | 1406 | N/A | N/A | N/A |
#4 | $13.9M | 69 | 44% | N/A | N/A |
#5 | $11.3M | 56 | 4% | N/A | N/A |
#6 | $11.5M | 57 | -7% | N/A | N/A |
#7 | $211.7M | 1072 | 4% | N/A | N/A |
#8 | $24.1M | 120 | 5% | N/A | N/A |
#9 | $7.8M | 39 | -2% | N/A | N/A |
#10 | $12.9M | 64 | -2% | N/A | N/A |
What Is AllianceRx Walgreens Prime?
AllianceRx Walgreens Prime is a specialty and mail service pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017 - through a collaboration between Walgreens, one of the nation's largest drugstore chains, and Prime Therapeutics, a leading pharmacy benefit manager - the pharmacy offers tools and resources for patients, providers and health plans to ensure optimal health outcomes. Headquartered in Orlando, Fla., AllianceRx Walgreens Prime's holds various accreditations from several national accrediting bodies. At AllianceRx Walgreens Prime, our vision is to be the pharmacy of choice to care for complex, chronic conditions and home delivery. With approximately 4,000 team members and several locations across the United States, AllianceRx Walgreens Prime serves patients nationwide. It offers tools and resources to help patients take their medicines as prescribed, 24/7 pharmacy support for exceptional care, and convenient pickup of specialty medications at any Walgreens retail locations nationwide. Our locations include: Orlando, FL (headquarters) Beaverton, OR Bethesda, MD Canton, MI Deerfield, IL Frisco, TX Irving, TX Pittsburgh, PA Tempe, AZ Visit www.alliancerxwp.com for more information.
keywords:N/A
N/A
Total Funding
1947
Number of Employees
$391.3M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AllianceRx Walgreens Prime News
ORLANDO, Fla., April 6, 2022 AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country,...
Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx...
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a...
Other LDDs now included through AllianceRx Walgreens Prime include Samsung Bioepis' Eticovo (etanercept-ykro), which is used to treat a ...
ORLANDO, Fla., Aug. 16, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the ...
Other Companies in Orlando
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $427.1M | 1991 | 9% | N/A |
#2 | $622.8M | 2170 | 17% | N/A |
#3 | $554.6M | 2216 | 10% | N/A |
#4 | $443.1M | 2367 | 19% | N/A |
#5 | $482.7M | 2411 | 5% | $25M |